JC

James Campbell

Patrys Limited | Chief Executive Officer, Managing Director
Dr Campbell has more than 20 years of international biotechnology research, management and leadership experience and has been involved in the creation and/or transformation of multiple Australian and international biotechnology companies. Dr Campbell was a foundation executive of Evolve Biosystems, and has assisted private biotechnology companies in Australia, New Zealand and the USA with capital raising and partnering negotiations. He is Chair of Risk Committee.

Companies and Roles

Company
Title
Tenure
Since
PAB
Patrys Limited
  • Chief Executive Officer
  • Managing Director
9yrs, 6mthNov 2014
PTX
Prescient Therapeutics Limited
  • Non-Executive Director
9yrs, 5mthNov 2014

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PAB
Patrys Limited
15/12/2317,383,1251,502,00036,000,000N/A
PTX
Prescient Therapeutics Limited
30/06/23396,365N/A1,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PAB
Patrys Limited
15/12/23
Expiry
401,544$0.008$3,212Options expired
PAB
Patrys Limited
22/11/23
Expiry
10,000,000$0.009$90,000Options expired
PAB
Patrys Limited
04/08/23
Expiry
399,415$0.010$3,994Options expired
PTX
Prescient Therapeutics Limited
01/05/23
Issued
136,231$0.098$13,350Exercise of options
PTX
Prescient Therapeutics Limited
01/05/23
Exercise
278,769$0.098$27,319Exercise of options